SGHT · Insider Trading

Sight Sciences, Inc. Common Stock

Every open-market purchase and sale reported by SGHT officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
50
most recent
Open-Market Buys
2
code P
Sales
30
code S
Reporting Insiders
16
current holders
SGHT — Recent Form 4 Transactions (latest 2026-10-05)
FiledInsiderRole TypeSharesValue
2026-10-05 Paul Badawi President and CEO Sell −29,653 −$268.33K
2026-10-05 Brenton Taylor EVP, Operations & R&D Sell −2,988 −$26.45K
2026-10-05 James Rodberg Chief Financial Officer Sell −7,208 −$63.81K
2026-10-05 David Badawi Chief Technology Officer Sell −7,797 −$70.56K
2026-10-05 Alison Bauerlein Chief Operating Officer Sell −25,260 −$223.63K
2026-08-18 Kashif Rashid Chief Legal Officer A +181,818 —
2026-07-06 Brenton Taylor EVP, Operations & R&D Sell −2,829 −$15.33K
2026-07-06 Alison Bauerlein Chief Operating Officer Sell −24,184 −$129.63K
2026-07-06 James Rodberg Chief Financial Officer Sell −6,902 −$36.99K
2026-07-06 Jeremy B. Hayden Chief Legal Officer Sell −12,733 −$70.13K
2026-07-06 Paul Badawi President and CEO Sell −28,684 −$155.47K
2026-07-06 David Badawi Chief Technology Officer Sell −7,418 −$40.86K
2026-06-11 Staffan Encrantz Director Buy +14,100 +$68.79K
2026-06-05 Gerhard F Burbach Director A +28,261 —
2026-06-05 Donald Zurbay Director A +28,261 —
2026-06-05 Tamara Fountain Director A +28,261 —
2026-06-05 Catherine Mazzacco Director A +28,261 —
2026-06-05 Staffan Encrantz Director A +28,261 —
2026-05-19 Alison Bauerlein Chief Operating Officer Sell −12,728 −$65.17K
2026-04-09 James Rodberg Chief Financial Officer Sell −7,231 −$25.67K
2026-04-09 Jeremy B. Hayden Chief Legal Officer Sell −13,761 −$48.85K
2026-04-03 Paul Badawi President and CEO Sell −29,244 −$108.20K
2026-04-03 David Badawi Chief Technology Officer Sell −8,168 −$28.42K
2026-04-03 Alison Bauerlein Chief Operating Officer Sell −25,874 −$90.04K
2026-04-03 Brenton Taylor EVP, Operations & R&D Sell −2,869 −$10.62K
2026-02-23 David Badawi Chief Technology Officer M +21,270 +$4.89K
2026-02-05 James Rodberg Chief Financial Officer A +86,940 —
2026-02-05 Paul Badawi President and CEO A +154,560 —
2026-02-05 David Badawi Chief Technology Officer A +64,915 —
2026-02-05 Brenton Taylor EVP, Operations & R&D A +100,464 —
2026-02-05 Jeremy B. Hayden Chief Legal Officer A +115,920 —
2026-02-05 Alison Bauerlein Chief Operating Officer A +127,512 —
2026-01-21 Jeremy B. Hayden Chief Legal Officer Sell −6,308 −$41.76K
2026-01-21 James Rodberg Chief Financial Officer Sell −2,616 −$17.32K
2026-01-21 Paul Badawi President and CEO Sell −22,362 −$148.04K
2026-01-21 David Badawi Chief Technology Officer Sell −4,836 −$32.01K
2026-01-06 Brenton Taylor EVP, Operations & R&D Sell −619 −$4.63K
2026-01-06 James Rodberg Chief Financial Officer Sell −4,999 −$38.89K
2026-01-06 Jeremy B. Hayden Chief Legal Officer Sell −11,170 −$86.74K
2026-01-06 David Badawi Chief Technology Officer Sell −9,660 −$73.15K
2026-01-06 Alison Bauerlein Chief Operating Officer Sell −20,543 −$157.37K
2026-01-06 Paul Badawi President and CEO Sell −37,226 −$277.18K
2025-12-30 David Badawi Chief Technology Officer M — —
2025-12-30 David Badawi Chief Technology Officer M +21,270 +$4.89K
2025-12-18 Staffan Encrantz Director Buy +13,958 +$115.96K
2025-12-03 James Rodberg Chief Financial Officer Sell −2,518 −$20.77K
2025-11-26 Jeremy B. Hayden Chief Legal Officer MIXED — −$274.48K
2025-11-18 Brenton Taylor EVP, Operations & R&D Sell −14,418 −$101.79K
2025-11-14 Jeremy B. Hayden Chief Legal Officer MIXED — −$19.06K
2025-11-13 James Rodberg Chief Financial Officer A +15,337 —
SGHT — Current Insider Holders
InsiderRole Shares HeldValue
Staffan Encrantz Director 6,521,203 $58.82M
Paul Badawi President and CEO 6,092,819 $54.96M
David Badawi Chief Technology Officer 1,975,075 $17.82M
Matthew Link Chief Commercial Officer 832,293 $7.51M
Alison Bauerlein Chief Operating Officer 639,449 $5.77M
Jeremy B. Hayden Chief Legal Officer 357,037 $3.22M
Brenton Taylor EVP, Operations & R&D 261,990 $2.36M
James Rodberg Chief Financial Officer 216,829 $1.96M
Donald Zurbay Director 193,613 $1.75M
Kashif Rashid Chief Legal Officer 181,818 $1.64M
Erica J. Rogers Director 175,352 $1.58M
Manohar K. Raheja EVP, Research & Development 167,767 $1.51M
Gerhard F Burbach Director 123,207 $1.11M
Tamara Fountain Director 109,650 $989.04K
Catherine Mazzacco Director 106,768 $963.05K
Brenda Jane Larsen-Becker Director 79,040 $712.94K
SGHT Insider Trading FAQ
Who are the insiders at SGHT?
16 officers, directors and 10%+ beneficial owners currently report holdings in SGHT via SEC Form 4.
Are SGHT insiders buying or selling?
Across the 50 most recent Form 4 filings for SGHT, 2 were open-market purchases (code P) and 30 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is SGHT insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent SGHT filing is dated 2026-10-05.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the SGHT quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.